Alpha Teknova (TKNO) Research & Development (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Research & Development came in at $2.1 million in Q1 2026, up 285.51% year-on-year from $552000.0 in Q1 2025, and up 177.02% on a QoQ basis from -$2.8 million in Q4 2025.
Alpha Teknova (TKNO) Research & Development (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Research & Development data on file, last reported at $2.1 million in Q1 2026.
- On a quarterly basis, Research & Development rose 285.51% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $488000.0, a 88.36% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 65.24% from the prior year.
- Research & Development for Q1 2026 stood at $2.1 million, up from -$2.8 million in the prior quarter.
- Over the last five years, Research & Development for TKNO reached as high as $2.4 million in Q4 2023 and fell as low as -$2.8 million in Q4 2025.
- Historically, Research & Development has averaged $1.2 million across 5 years, with a median of $1.5 million in 2024.
- Across the five-year window, Research & Development sank 277.46% in 2025 and soared 285.51% in 2026, its largest moves.
- Year by year, Research & Development stood at $1.1 million in 2022, then surged by 109.69% to $2.4 million in 2023, then tumbled by 35.15% to $1.6 million in 2024, then sank by 277.46% to -$2.8 million in 2025, then soared by 177.02% to $2.1 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $2.1 million in Q1 2026, -$2.8 million in Q4 2025, and $542000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 138.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Sep 30, 2025 | 542,000.00 |
| Jun 30, 2025 | 581,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 627,000.00 |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 860,000.00 |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Sep 30, 2022 | 1.93 Mn |
| Jun 30, 2022 | 1.93 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 855,000.00 |
| Sep 30, 2021 | 1.37 Mn |
| Jun 30, 2021 | 851,000.00 |